Peptic Ulcers

6 registered clinical trials studyying Peptic Ulcers.

Status	Trial	Sponsor	Phase
Completed	Risk Factors Affecting Mortality in Perforated Peptic Ulcer NCT07050199	Maharajgunj Medical Campus	—
Unknown	Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis NCT01182597	National Taiwan University Hospital	Phase 3
Withdrawn	Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleedin NCT00247130	Keio University	Phase 4
Completed	High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding NCT00374101	Casa Sollievo della Sofferenza IRCCS	Phase 3
Completed	Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population NCT00137033	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708) NCT00261300	Takeda	Phase 3